Alaunos Therapeutics Announces Acquisition of Velaris Therapeutics

Acquisition of Velaris and concurrent oversubscribed $350 million private placement positions the Company to deliver multiple proof-of-concept datasets in pulmonary arterial hypertension Velaris...